Chris Storgard - Concepedia

Author

Chris Storgard

AstraZeneca (United States)

Also Known As

C. Storgard, C.M. Storgard, Chris M. Storgard, Chris Storgard, D. Von Hoff

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)University of Auckland University of Michigan University of Alabama at Birmingham East–West Center

About

Chris Storgard is an author at AstraZeneca (United States) specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	232
2	Anesthesia	1	1	49
3	Biomedical Engineering	1	1	55
4	Cell Biology	1	1	55
5	Cellular Physiology	1	1	55

Chris Storgard

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins Dwayne G. Stupack, Xosé S. Puente, Souphaphone Boutsaboualoy, The Journal of Cell Biology	2001	539
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist Chris Storgard, Dwayne G. Stupack, Alfred Jonczyk, Journal of Clinical Investigation	1999	309
Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study) Kenneth G. Saag, David Fitzpatrick, Jeff Kopicko, Arthritis & Rheumatology	2016	174
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study) Thomas Bardin, Robert T. Keenan, Puja Khanna, Annals of the Rheumatic Diseases	2016	161
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial Nicola Dalbeth, Graeme Jones, Robert Terkeltaub, Arthritis & Rheumatology	2017	150
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth, Lara D. Veeken	2017	113
An open-label, 6-month study of allopurinol safety in gout: The LASSO study Michael A. Becker, David Fitzpatrick, Hyon K. Choi, Seminars in Arthritis and Rheumatism	2015	106
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol Fernando Pérez-Ruiz, John S. Sundy, Jeffrey N. Miner, Annals of the Rheumatic Diseases	2016	98
Targeted Measles Virus Vector Displaying Echistatin Infects Endothelial Cells via αvβ3 and Leads to Tumor Regression Louay K. Hallak, Jaime R. Merchan, Chris Storgard, Cancer Research	2005	61
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males Zancong Shen, Colin Rowlings, Brad Kerr, Drug Design Development and Therapy	2015	55

Page 1